MolMed S.p.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
5,856.00
11,181.00
13,576.00
19,484.00
23,000.00
Cost of Goods Sold (COGS) incl. D&A
20,865.00
21,790.00
34,831.00
32,885.00
22,018.00
Gross Income
15,009.00
10,609.00
21,255.00
13,401.00
982.00
SG&A Expense
3,615.00
3,134.00
2,432.00
3,459.00
10,055.00
EBIT
18,744.00
13,869.00
22,968.00
-
9,073.00
Unusual Expense
78.00
-
-
-
-
Non Operating Income/Expense
848.00
1,084.00
2,071.00
1,496.00
556.00
Interest Expense
292.00
269.00
-
-
-
Pretax Income
18,169.00
13,003.00
20,784.00
13,876.00
8,497.00
Consolidated Net Income
18,169.00
13,003.00
20,784.00
13,876.00
8,497.00
Net Income
18,169.00
13,003.00
20,784.00
13,876.00
8,497.00
Net Income After Extraordinaries
18,169.00
13,003.00
20,784.00
13,876.00
8,497.00
Net Income Available to Common
18,169.00
13,003.00
20,784.00
13,876.00
8,497.00
EPS (Basic)
0.07
0.05
0.06
0.03
0.02
Basic Shares Outstanding
267,736.50
285,294.60
375,765.80
421,724.70
437,236.70
EPS (Diluted)
0.07
0.05
0.06
0.03
0.02
Diluted Shares Outstanding
267,736.50
285,294.60
375,765.80
421,724.70
437,236.70
EBITDA
18,233.00
13,458.00
22,342.00
14,355.00
7,724.00
Other Operating Expense
120.00
126.00
719.00
1,412.00
-
Non-Operating Interest Income
97.00
51.00
113.00
76.00
20.00
About MolMed
View Profile
